^
+ Follow ARICEPT AND NAMENDA Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 

Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

[DatePublished] => 2013-06-14 08:00:48 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => World [SectionUrl] => world [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg ) [1] => Array ( [ArticleID] => 867025 [Title] => New gene triples risk for Alzheimer's disease [Summary] =>

Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer's disease, giving a fresh target for research into treatments for the mind-robbing disorder.

 
[DatePublished] => 2012-11-15 14:22:38 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://img690.imageshack.us/img690/3810/alzheimerthumb.jpg ) [2] => Array ( [ArticleID] => 857745 [Title] => Alzheimer drug shows some promise in mild disease [Summary] =>

Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.

[DatePublished] => 2012-10-09 09:32:06 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => http://imageshack.us/a/img856/8255/alzheimersdrug2thumb.jpg ) [3] => Array ( [ArticleID] => 848170 [Title] => Studies: Alzheimer drug may stabilize brain plaque [Summary] =>

An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.

[DatePublished] => 2012-09-12 10:22:35 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) [4] => Array ( [ArticleID] => 829079 [Title] => Small study: Drug may help stabilize Alzheimer's [Summary] =>

For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and found in only four patients.

[DatePublished] => 2012-07-18 09:30:28 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) ) )
ARICEPT AND NAMENDA
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 

Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

[DatePublished] => 2013-06-14 08:00:48 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => World [SectionUrl] => world [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg ) [1] => Array ( [ArticleID] => 867025 [Title] => New gene triples risk for Alzheimer's disease [Summary] =>

Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer's disease, giving a fresh target for research into treatments for the mind-robbing disorder.

 
[DatePublished] => 2012-11-15 14:22:38 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://img690.imageshack.us/img690/3810/alzheimerthumb.jpg ) [2] => Array ( [ArticleID] => 857745 [Title] => Alzheimer drug shows some promise in mild disease [Summary] =>

Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.

[DatePublished] => 2012-10-09 09:32:06 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => http://imageshack.us/a/img856/8255/alzheimersdrug2thumb.jpg ) [3] => Array ( [ArticleID] => 848170 [Title] => Studies: Alzheimer drug may stabilize brain plaque [Summary] =>

An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.

[DatePublished] => 2012-09-12 10:22:35 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) [4] => Array ( [ArticleID] => 829079 [Title] => Small study: Drug may help stabilize Alzheimer's [Summary] =>

For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and found in only four patients.

[DatePublished] => 2012-07-18 09:30:28 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with